Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $25.73. The company's market cap stands at 148.79B, with a P/E ratio of 15.08 and a dividend yield of 6.6%.
On 2025-11-14, Pfizer(PFE) stock moved within a range of $25.66 to $26.48. With shares now at $25.73, the stock is trading +0.3% above its intraday low and -2.8% below the session's peak.
Trading activity shows a volume of 123.08M, compared to an average daily volume of 129.66M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
PFE News
Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...
Pfizer’s shares (PFE) edged higher on Thursday after shareholders of Metsera (MTSR) approved the American pharma giant’s offer of up to $10 billion to take over...
Pfizer (PFE) announced the successful completion of its acquisition of Metsera (MTSR). “Pfizer has completed its acquisition of all outstanding shares of common...
Analyst ratings
58%
of 26 ratingsMore PFE News
Pfizer (NYSE:PFE) is reportedly offloading its remaining stake in Covid-19 vaccine partner BioNTech SE (NASDAQ:BNTX) . BNTX is among today's weakest performers...
Shares of Mangoceuticals (MGRX), the Texas-based telehealth company focused on men’s health, rose sharply in early trading on Thursday, climbing 24.43% to $2.19...
Pfizer (PFE) is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech (BNTX), Bloomberg’s Sonja Wind and Anthony Hughes reports. Pfizer is of...
Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive dividend stock. Merck (MRK +0.53%) has a...
The biotech start-up's stock had been rising rapidly in 2025. Innovative biopharmaceutical company Metsera (MTSR 0.10%) has been climbing all year. It went pub...
Analyst Terence Flynn of Morgan Stanley maintained a Hold rating on Pfizer, retaining the price target of $32.00. Meet Your ETF AI Analyst Discover how TipRanks...
Key Points Pfizer's sales and profits came in better than expected for the third quarter. The stock, however, remains down for the year. Concerns about the c...
